A comparison of the inhibitory effect of nano-encapsulated helenalin and free helenalin on telomerase gene expression in the breast cancer cell line, by real-time PCR
Source abstract
Abstract
BACKGROUND: The up-regulation of telomerase gene expression occurs in numerous cancers such as breast cancer. A recent study used the PLGA-PEG-helenalin complex, and free helenalin, to inhibit the expression of telomerase in the breast cancer cell line. The purpose of this study was to examine whether nano encapsulating helenalin improves the anti-cancer effect of free helenalin in the T47D breast cancer cell line. METHOD: The breast cancer cell line (T47D) was grown in the RPMI 1640 medium, supplemented with 10% FBS. The helenalin was encapsulated by the double emulsion method. Then, the drug loading was calculated and its morphology identified by SEM. Other properties of this copolymer were characterized by Fourier transform infrared (FTIR) spectroscopy and H nuclear magnetic resonance (H NMR) spectroscopy. The assessment of drug cytotoxicity on the growth of the breast cancer cell line was carried out through MTT assay. After treating the cells with a given amount of drug, RNA was extracted and cDNA was synthesized. In order to assess the amount of telomerase gene expression, real-time PCR was performed. RESULTS: With regard to the amount of the drug loaded, IC50 value was significantly decreased in nanocapsulated (NC) helenalin, in comparison with that of free helenalin. This finding has been proved through the decrease of telomerase gene expression by real-time PCR. CONCLUSION: In this study, we demonstrated that the NC-helenalin complex is more effective than free helenalin in inhibiting the growth of breast cancer cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Telomeres, Telomerase, and Senescence · Bee Products Chemical Analysis · Natural product bioactivities and synthesis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Medical Biotechnology, Faculty of Advanced Medical Science
Radiopharmacy Lab, Drug Applied Research Center, Tabriz University of Medical Sciences
Department of Medical Biotechnology, School of Medicine, Tabriz University of Medical Sciences
Department of Medical Nanotechnology, Faculty of Advanced Medical Science
Department of Clinical Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences
References (67)
Show source-provided references
1. Abbasi E, Akbarzadeh A, Kouhi M, Milani M. 2014a. Graphene: synthesis, bio-applications, and properties. Artif Cells Nanomed Biotechnol. 30:1–7.
2. 10.1186/1556-276X-9-24710.1186/1556-276X-9-247 ↗
3. 10.3109/1040841X.2014.91220010.3109/1040841X.2014.912200 ↗
4. 10.3109/1040841X.2014.91220010.3109/1040841X.2014.912200 ↗
5. 10.1007/s11033-013-3014-410.1007/s11033-013-3014-4 ↗
6. Akbarzadeh A, Mikaeili H, Asgari D, Zarghami N, Mohammad R, Davaran S. 2012b. Preparation and in-vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers Int J Nanomedicine 7:511–526.
7. 10.1186/1556-276X-8-10210.1186/1556-276X-8-102 ↗
8. 10.1186/1556-276X-7-14410.1186/1556-276X-7-144 ↗
9. 10.1186/1477-3155-10-4610.1186/1477-3155-10-46 ↗
10. Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khiabani HK, Davaran S. 2012c. Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Int J Nanotechnol Sci Environ 5:13–25.
11. 10.2174/15680091179432849310.2174/156800911794328493 ↗
12. 10.7314/APJCP.2014.15.1.4910.7314/APJCP.2014.15.1.49 ↗
13. Alizadeh E, Akbarzadeh A, Eslaminejad MB, Barzegar A, Hashemzadeh S, Nejati-Koshki K, Zarghami N. 2014a. Up-regulation of Liver enriched Transcription Factors (HNF4a and HNF6) and Liver Specific MicroRNA (miR-122) by Inhibition of Let-7b in Mesenchymal Stem Cells. Chem Biol Drug Des 85:600–608.
14. Alizadeh E, Zarghami N, Eslaminejad MB, Akbarzadeh A, Barzegar A, Mohammadi SA. 2014b. The effect of dimethyl sulfoxide (DMSO) on hepatic differentiation of mesenchymal stem cells. Artif Cells Nanomed Biotechnol. 30:1–8.
15. Anganeh MT, Sadat Tabatabaei Mirakabad F, Izadi M, Zeighamian V, Badrzadeh F, Salehi R, et al 2014. The comparison between effects of free curcumin and curcumin loaded PLGA-PEG on telomerase and TRF1 expressions in calu-6 lung cancer cell line. Int J Biosci. 4:134–145.
16. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. 1996. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 56:645–650.
17. 10.1038/7959410.1038/79594 ↗
18. 10.1155/S111072430100010910.1155/S1110724301000109 ↗
19. 10.1126/science.279.5349.34910.1126/science.279.5349.349 ↗
20. Chung JH, Kim YK, Kim KH, Kwon TY, Vaezmomeni SZ, Samiei M, et al. 2014. Synthesis, characterization, biocompatibility of hydroxyapatite-natural polymers nanocomposites for dentistry applications. Artif Cells Nanomed Biotechnol. 1–8.
21. Daraee H, Eatemadi A, Abbasi E, Fekri Aval S, Kouhi M, Akbarzadeh A. 2014a. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 1–13.
22. Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. 2014b. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 1–11.
23. 10.4236/jeas.2013.3401310.4236/jeas.2013.34013 ↗
24. 10.4236/anp.2014.3100310.4236/anp.2014.31003 ↗
25. 10.7314/APJCP.2014.15.10.435310.7314/APJCP.2014.15.10.4353 ↗
26. 10.1055/s-2001-1647810.1055/s-2001-16478 ↗
27. Dirsch VM, Stuppner H, Vollmar AM. 2001b. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by over expression of Bcl-x(L) or Bcl-2. Cancer Res. 61:5817–5823.
28. 10.1186/1556-276X-9-39310.1186/1556-276X-9-393 ↗
29. Eatemadi A, Daraee H, Zarghami N, Yar HM, Akbarzadeh A, Hanifehpour Y. 2014b. Nanofiber; synthesis and biomedical applications. Artif Cells Nanomed Biotechnol. (Epub ahead of print).
30. Ebrahimi E, Akbarzadeh A, Abbasi E, Khandaghi AA, Abasalizadeh F, Davaran S. 2014. Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer. Artif Cells Nanomed Biotechnol.(Epub ahead of print).
31. Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh A, Rahmati M, et al. 2013. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. BioImpacts 3:67–74.
32. 10.1109/LAWP.2010.204381010.1109/LAWP.2010.2043810 ↗
33. Fekri Aval S, Akbarzadeh A, Yamchi MR, Zarghami F, Nejati-Koshki K, Zarghami N. 2014. Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line. Artif Cells Nanomed Biotechnol. 1–6.
34. 10.1126/science.754449110.1126/science.7544491 ↗
35. 10.7314/APJCP.2014.15.17.711310.7314/APJCP.2014.15.17.7113 ↗
36. 10.7314/APJCP.2013.14.11.694910.7314/APJCP.2013.14.11.6949 ↗
37. 10.2174/18722110978845227610.2174/187221109788452276 ↗
38. Hankey. 1992. Cancer statistics review 1973–1989. National Cancer Institute, NIH Pub. 92–2789:1–8.
39. 10.1111/cbdd.1231810.1111/cbdd.12318 ↗
40. 10.1016/j.canlet.2004.11.04510.1016/j.canlet.2004.11.045 ↗
41. 10.1016/S0927-7765(99)00162-910.1016/S0927-7765(99)00162-9 ↗
42. 10.1007/s11033-014-3553-310.1007/s11033-014-3553-3 ↗
43. 10.1186/bcr277010.1186/bcr2770 ↗
44. 10.1093/hmg/6.12.201110.1093/hmg/6.12.2011 ↗
45. 10.1126/science.760542810.1126/science.7605428 ↗
46. 10.1186/1556-276X-9-13110.1186/1556-276X-9-131 ↗
47. 10.1038/sj.onc.120516310.1038/sj.onc.1205163 ↗
48. 10.1126/science.276.5312.56110.1126/science.276.5312.561 ↗
49. 10.1074/jbc.273.50.3350810.1074/jbc.273.50.33508 ↗
50. 10.1016/S0092-8674(00)80538-310.1016/S0092-8674(00)80538-3 ↗
51. 10.7314/APJCP.2013.14.11.692510.7314/APJCP.2013.14.11.6925 ↗
52. Nasrabadi HT, Abbasi E, Davaran S, Kouhi M, Akbarzadeh A. 2014. Bimetallic nanoparticles: Preparation, properties, and biomedical applications. Artif Cells Nanomed Biotechnol. 1–5.
53. 10.7314/APJCP.2013.14.11.659510.7314/APJCP.2013.14.11.6595 ↗
54. 10.3109/02652048.2014.94001110.3109/02652048.2014.940011 ↗
55. 10.1016/S0378-1119(01)00440-110.1016/S0378-1119(01)00440-1 ↗
56. 10.1186/1556-276X-8-48510.1186/1556-276X-8-485 ↗
57. Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A, Rahmati-Yamchi M, Gholizadeh D, Akbarzadeh A, et al. 2014. Watercress-based gold nanoparticles: biosynthesis, mechanism of formation and study of their biocompatibility in vitro. IET Dig Lib 4:5.
58. 10.4236/soft.2013.2300410.4236/soft.2013.23004 ↗
59. Sadat Tabatabaei Mirakabad F, Akbarzadeh A, Zarghami N, Zeighamian V, Rahimzadeh A, Alimohammadi S 2014. PLGA-based nanoparticles as cancer drug delivery systems Asian Pac J Cancer Prev. 15:517–535.
60. 10.1093/carcin/bgh29610.1093/carcin/bgh296 ↗
61. 10.1038/3503609310.1038/35036093 ↗
62. Tabatabaei Mirakabad FS, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, et al. 2014. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cell Nanomed Biotechnol. 1–8.
63. Torbbaghan S. 1999. Annual report of Tehran University of medical sciences district cancer registry (TUMS-DCR). The cancer institute publication, No. 7, 43.
64. 10.1186/1556-276X-7-48010.1186/1556-276X-7-480 ↗
65. 10.1128/MCB.19.6.398910.1128/MCB.19.6.3989 ↗
66. Yuan M, Wang Y, Li X, Xiong C, Deng X. 2014. Polymerization of lactides and lactones. Synthesis, characterization, and application of amino–terminated poly (ethylene glycol)–co–poly ([e]–caprolactone) block copolymer. Macromolecules. 33:1613–1617.
67. 10.1007/s00018-007-6481-810.1007/s00018-007-6481-8 ↗